complication
transplant
mammalian target of rapamycin inhibitors
mTOR-i
interstitial fibrosis
atrophy
glomerulopathy
amyloidosis
renal
transplant
patient
transplant
monoclonal gammapathy of undetermined significance
tacrolimus
everolimus
